Dysfunction of blood pressure regulation in hyperhomocyteinemia model in rats

Atsushi Miyajima1, Masaru Bamba, Takafumi Muto

  • 1Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science.

Insights

Hyperhomocysteinemia (HHC) impairs blood pressure regulation and damages the aorta in rats. This suggests HHC increases cardiovascular disease risk through aortic damage, not oxidative stress.

Area of Science:

  • Cardiovascular Science
  • Physiology
  • Pathology

Background:

  • Hyperhomocysteinemia (HHC) is a known risk factor for cardiovascular disease.
  • Understanding HHC's specific impact on vascular function and structure is crucial for risk assessment.

Purpose of the Study:

  • To investigate the effects of HHC on blood pressure regulation in rats.
  • To examine the association between HHC, thoracic aorta damage, and plasma redox balance.

Main Methods:

  • A subchronic HHC model was established in rats using methionine-enriched diets for 16 weeks.
  • Systolic blood pressure responses to L-epinephrine were measured.
  • Aortic tissue and plasma redox indicators were analyzed.

Main Results:

  • HHC significantly increased systolic blood pressure response to sympathetic stimulation (2- to 3-fold higher).
  • Disruption of elastic lamellae in the thoracic aorta was observed in HHC rats.
  • No significant differences in aortic cross-linkages or plasma redox markers (TBARS, glutathione) were found.

Conclusions:

  • HHC deteriorates vaso-regulatory function, potentially increasing cardiovascular event risk.
  • Aortic elastic lamellae damage, not oxidative stress, appears to be the primary cause of vaso-regulation impairment in this HHC model.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
783
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K